{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:52:08Z","timestamp":1791748328892,"version":"4.3.4"},"reference-count":72,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,7]]},"abstract":"<jats:p>Strongyloidiasis is an intestinal parasitic infection becoming increasingly important outside endemic areas, not only because of the high prevalence found in migrant populations, but also because immunosuppressed patients may suffer a potentially fatal disseminated disease. The aim of these guidelines is to provide evidence-based guidance for screening and treatment of strongyloidiasis in non-endemic areas. A panel of experts focused on three main clinical questions (who should be screened and how, how to treat), and reviewed pertinent literature available in international databases of medical literature and in documents released by relevant organizations\/societies. A consensus of the experts\u2019 opinion was sought when specific issues were not covered by evidence. In particular, six systematic reviews were retrieved and constituted the main support for this work. The evidence and consensus gathered led to recommendations addressing various aspects of the main questions. Grading of evidence and strength of recommendation were attributed to assess the quality of supporting evidence. The screening of individuals at risk of the infection should be performed before they develop any clinical complication. Moreover, in immunosuppressed patients, the screening should be mandatory. The screening is based on a simple and widely accessible technology and there is now a universally accepted treatment with a high efficacy rate. Therefore, the screening could be implemented as part of a screening program for migrants although further cost-effectiveness studies are required to better evaluate this strategy from a public health point of view.<\/jats:p>","DOI":"10.4269\/ajtmh.16-0923","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T07:00:44Z","timestamp":1500966044000},"page":"645-652","source":"Crossref","is-referenced-by-count":120,"title":["Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries"],"prefix":"10.4269","volume":"97","author":[{"given":"Ana","family":"Requena-M\u00e9ndez","sequence":"first","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal-CRESIB), Hospital Cl\u00ednic-Universitat de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Buonfrate","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Gomez-Junyent","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal-CRESIB), Hospital Cl\u00ednic-Universitat de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Zammarchi","sequence":"additional","affiliation":[{"name":"Clinica Malattie Infettive, Dipartimento di Medicina Sperimentale e Clinica, Universita Degli Studi di Firenze, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Bisoffi","sequence":"additional","affiliation":[{"name":"Centre for Tropical Diseases, Sacro Cuore Hospital, Negrar, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal-CRESIB), Hospital Cl\u00ednic-Universitat de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"BMJ","first-page":"f4610","article-title":"Strongyloides stercoralis infection","volume":"347","author":"Greaves","year":"2013"},{"key":"b2","series-title":"PLoS Negl Trop Dis","first-page":"e2214","article-title":"Strongyloides stercoralis: a plea for action","volume":"7","author":"Bisoffi","year":"2013"},{"key":"b3","series-title":"Curr Infect Dis Rep","first-page":"256","article-title":"Imported strongyloidiasis: epidemiology, presentations, and treatment","volume":"14","author":"Buonfrate","year":"2012"},{"key":"b4","series-title":"Curr Opin Infect Dis","first-page":"500","article-title":"Strongyloides stercoralis: there but not seen","volume":"23","author":"Montes","year":"2010"},{"key":"b5","author":"Sch\u00e4r","year":"2013"},{"key":"b6","series-title":"Trans R Soc Trop Med Hyg","first-page":"613","article-title":"Clinical and epidemiological features of 33 imported Strongyloides stercoralis infections","volume":"104","author":"Gonzalez","year":"2010"},{"key":"b7","series-title":"Epidemiol Infect","first-page":"452","article-title":"Prevalence of strongyloidiasis in Latin America: a systematic review of the literature","volume":"143","author":"Buonfrate","year":"2015"},{"key":"b8","series-title":"Curr Trop Med Rep","article-title":"Advances in the diagnosis of human strongyloidiasis","volume":"1","author":"Requena-M\u00e9ndez","year":"2014"},{"key":"b9","series-title":"WormBook","first-page":"1","article-title":"The biology of Strongyloides spp","author":"Viney","year":"2015"},{"key":"b10","series-title":"BMC Infect Dis","first-page":"78","article-title":"Severe strongyloidiasis: a systematic review of case reports","volume":"13","author":"Buonfrate","year":"2013"},{"key":"b11","series-title":"Clin Microbiol Rev","first-page":"208","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","author":"Keiser","year":"2004"},{"key":"b12","series-title":"PLoS Negl Trop Dis","first-page":"e1581","article-title":"Is human immunodeficiency virus infection a risk factor for Strongyloides stercoralis hyperinfection and dissemination","volume":"6","author":"Siegel","year":"2012"},{"key":"b13","series-title":"Am J Trop Med Hyg","first-page":"146","article-title":"Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru","volume":"60","author":"Gotuzzo","year":"1999"},{"key":"b14","series-title":"Am J Transplant","first-page":"1003","article-title":"Considerations for screening live kidney donors for endemic infections: a viewpoint on the UNOS policy","volume":"14:","author":"Levi","year":"2014"},{"key":"b15","series-title":"Transplantation","first-page":"1019","article-title":"Donor-derived Strongyloides stercoralis infections in renal transplant recipients","volume":"91","author":"Hamilton","year":"2011"},{"key":"b16","series-title":"Am J Transplant","first-page":"2483","article-title":"Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor","volume":"13","author":"Roseman","year":"2013"},{"key":"b17","series-title":"Am J Transplant","first-page":"1199","article-title":"Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature","volume":"14","author":"Le","year":"2014"},{"key":"b18","series-title":"Eur Respir J","first-page":"1180","article-title":"Migrant tuberculosis screening in the EU\/EEA: yield, coverage and limitations","volume":"34","author":"Klinkenberg","year":"2009"},{"key":"b19","series-title":"Int J STD AIDS","first-page":"402","article-title":"Case finding advantage of HIV rapid tests in community settings: men who have sex with men in 12 programme areas in China, 2011","volume":"26","author":"Zhang","year":"2015"},{"key":"b20","series-title":"Euro Surveill","article-title":"Epidemiology of Strongyloides stercoralis in northern Italy: results of a multicentre case-control study, February 2013 to July 2014","author":"Buonfrate","year":"2016"},{"key":"b21","series-title":"J Infect","first-page":"152","article-title":"Characteristics and geographical profile of strongyloidiasis in healthcare area 11 of the Valencian community (Spain).","volume":"49","year":"2004"},{"key":"b22","series-title":"PLoS Negl Trop Dis","first-page":"e2002","article-title":"The laboratory diagnosis and follow up of strongyloidiasis: a systematic review","volume":"7","author":"Requena-M\u00e9ndez","year":"2013"},{"key":"b23","series-title":"PLoS Negl Trop Dis","first-page":"e2640","article-title":"Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection","volume":"8","author":"Bisoffi","year":"2014"},{"key":"b24","series-title":"PLoS Negl Trop Dis","first-page":"e0003491","article-title":"Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection","volume":"9","author":"Buonfrate","year":"2015"},{"key":"b25"},{"key":"b26","series-title":"Curr Infect Dis Rep","first-page":"256","article-title":"Imported strongyloidiasis: epidemiology, presentations, and treatment","volume":"14","author":"Buonfrate","year":"2012"},{"key":"b27","series-title":"N Engl J Med","first-page":"773","article-title":"The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants","volume":"340","author":"Muennig","year":"1999"},{"key":"b28","series-title":"Epidemiol Infect","first-page":"1055","article-title":"The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States","volume":"132","author":"Muennig","year":"2004"},{"key":"b29","series-title":"PLoS Negl Trop Dis","first-page":"e1254","article-title":"Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis","volume":"5","author":"Bisoffi","year":"2011"},{"key":"b30","series-title":"J Infect","first-page":"1","article-title":"Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management","volume":"60","author":"Checkley","year":"2010"},{"key":"b31","author":"Caruana"},{"key":"b32","series-title":"Epidemiol Infect","first-page":"439","article-title":"Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7\u201320 years after resettlement in Australia","volume":"128","author":"de Silva","year":"2002"},{"key":"b33","series-title":"Ann Trop Med Parasitol","first-page":"617","article-title":"Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009","volume":"105","author":"Mascarello","year":"2011"},{"key":"b34","series-title":"BMC Infect Dis","first-page":"84","article-title":"Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: the risk of infection and the diagnostic relevance of blood eosinophilia","volume":"11","author":"Baaten","year":"2011"},{"key":"b35","series-title":"Clin Infect Dis","first-page":"353","article-title":"Screening for schistosomiasis, filariasis, and strongyloidiasis among expatriates returning from the tropics","volume":"17","author":"Libman","year":"1993"},{"key":"b36","series-title":"Trans R Soc Trop Med Hyg","first-page":"314","article-title":"Strongyloides hyperinfection syndrome: an emerging global infectious disease","volume":"102","author":"Marcos","year":"2008"},{"key":"b37","series-title":"Southeast Asian J Trop Med Public Health","first-page":"875","article-title":"Risk factors for strongyloidiasis hyperinfection and clinical outcomes","volume":"37","author":"Asdamongkol","year":"2006"},{"key":"b38","series-title":"Clin Microbiol Infect","first-page":"945","article-title":"Severe strongyloidiasis in corticosteroid-treated patients","volume":"12","author":"Fardet","year":"2006"},{"key":"b39","series-title":"Clin Infect Dis","first-page":"1040","article-title":"Diagnosis of Strongyloides stercoralis infection","volume":"33","author":"Siddiqui","year":"2001"},{"key":"b40","series-title":"Zentralbl Bakteriol Mikrobiol Hyg A","first-page":"616","article-title":"Improved diagnosis of Strongyloides stercoralis by seven consecutive stool specimens","volume":"263","author":"Nielsen","year":"1987"},{"key":"b41","series-title":"Rev Esp Salud Publica","first-page":"581","volume":"88","author":"Campo Polanco","year":"2014"},{"key":"b42","series-title":"Clin Vaccine Immunol","first-page":"129","article-title":"Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up","volume":"14","author":"Boscolo","year":"2007"},{"key":"b43","series-title":"Trans R Soc Trop Med Hyg","first-page":"535","article-title":"Gelatin particle indirect agglutination and enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis using Strongyloides venezuelensis antigen","volume":"97","author":"Huaman","year":"2003"},{"key":"b44","series-title":"Mem Inst Oswaldo Cruz","first-page":"687","article-title":"Western blotting using Strongyloides ratti antigen for the detection of IgG antibodies as confirmatory test in human strongyloidiasis","volume":"98","author":"Silva","year":"2003"},{"key":"b45","series-title":"Am J Trop Med Hyg","first-page":"175","article-title":"Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection","volume":"51","author":"Lindo","year":"1994"},{"key":"b46","series-title":"J Infect Dis","first-page":"427","article-title":"Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans","volume":"144","author":"Neva","year":"1981"},{"key":"b47","author":"Mangali","year":"1991"},{"key":"b48","series-title":"Am J Trop Med Hyg","first-page":"749","article-title":"Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area","volume":"66","author":"Loutfy","year":"2002"},{"key":"b49","series-title":"J Clin Microbiol","first-page":"438","article-title":"Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans","volume":"45","author":"van Doorn","year":"2007"},{"key":"b50","author":"Sudarshi","year":"2003"},{"key":"b51","series-title":"J Travel Med","first-page":"138","article-title":"Acute strongyloidiasis in Italian tourists returning from southeast Asia","volume":"18","author":"Angheben","year":"2011"},{"key":"b52","author":"Luvira","year":"2016"},{"key":"b53","series-title":"Cochrane Database Syst Rev","first-page":"CD007745","article-title":"Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection","author":"Henriquez-Camacho","year":"2016"},{"key":"b54","series-title":"Am J Trop Med Hyg","first-page":"263","article-title":"Albendazole: a new broad spectrum anthelmintic. Double-blind multicenter clinical trial","volume":"31","author":"Pene","year":"1982"},{"key":"b55","series-title":"Southeast Asian J Trop Med Public Health","first-page":"32","article-title":"Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis","volume":"37","author":"Singthong","year":"2006"},{"key":"b56","author":"Datry"},{"key":"b57","series-title":"Am J Trop Med Hyg","first-page":"477","article-title":"A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children","volume":"55","author":"Marti","year":"1996"},{"key":"b58","series-title":"Southeast Asian J Trop Med Public Health","first-page":"147","article-title":"Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan","volume":"31","author":"Toma","year":"2000"},{"key":"b59","series-title":"Southeast Asian J Trop Med Public Health","first-page":"442","volume":"36","author":"Nontasut","year":"2005"},{"key":"b60","series-title":"PLoS Negl Trop Dis","first-page":"e1044","article-title":"Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis","volume":"5","author":"Suputtamongkol","year":"2011"},{"key":"b61","series-title":"Southeast Asian J Trop Med Public Health","first-page":"735","article-title":"A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis","volume":"26","author":"Pitisuttithum","year":"1995"},{"key":"b62","series-title":"J Infect Dis","first-page":"1076","article-title":"A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis","volume":"169","author":"Gann","year":"1994"},{"key":"b63","series-title":"Afr J Biotechnol","article-title":"Comparison of ivermectin and thiabendazole in the treatment of uncomplicated human Strongyloides stercoralis infection","volume":"2","author":"Adenusi","year":"2003"},{"key":"b64","series-title":"PLoS Negl Trop Dis","first-page":"e1254","article-title":"Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis","volume":"5","author":"Bisoffi","year":"2011"},{"key":"b65","series-title":"Curr Opin Infect Dis","first-page":"458","article-title":"Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis","volume":"25","author":"Mejia","year":"2012"},{"key":"b66","year":"2008"},{"key":"b67"},{"key":"b68","series-title":"Clin Infect Dis","first-page":"1411","article-title":"Strongyloidiasis in transplant patients","volume":"49","author":"Roxby","year":"2009"},{"key":"b69","series-title":"Am J Trop Med Hyg","first-page":"788","article-title":"Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?","volume":"80","author":"Biggs","year":"2009"},{"key":"b70","series-title":"Am J Trop Med Hyg","first-page":"830","article-title":"Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia","volume":"90","author":"Salvador","year":"2014"},{"key":"b71","series-title":"Trans R Soc Trop Med Hyg","first-page":"1056","article-title":"Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy","volume":"100","author":"Page","year":"2006"},{"key":"b72","series-title":"Int J Antimicrob Agents","first-page":"46","article-title":"Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis","volume":"31","author":"Suputtamongkol","year":"2008"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/97\/3\/article-p645.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/97\/3\/article-p645.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/97\/3\/article-p645.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T22:32:48Z","timestamp":1722465168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/97\/3\/article-p645.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":72,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.16-0923","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}